期刊文献+

艰难梭菌毒素AC端结构域在大肠杆菌中的可溶性表达与卵黄抗体的制备 被引量:7

Expression of C-terminal domain of Clostridium difficile toxin A and production of yolk antibody IgY against recombinant toxin A
原文传递
导出
摘要 目的重组表达艰难梭菌毒素A的C端结构域,制备针对艰难梭菌毒素A C端结构域的卵黄抗体。方法将优化合成的艰难梭菌毒素A的C端结构域DNA片段克隆到表达载体pET32b(+)上,重组质粒转入大肠杆菌中诱导表达,经高亲和镍离子树脂纯化得到融合蛋白,凝血酶酶切后用高亲和镍离子树脂吸附多余多肽获得目的蛋白。检测目的蛋白的生物学活性,用目的蛋白免疫产蛋鸡制备针对艰难梭菌毒素A受体结合区的鸡卵黄抗体,分离纯化鸡卵黄抗体并用ELISA测定卵黄抗体的效价。结果获得了优化的艰难梭菌毒素A受体结合区的基因片段,继而制备了具有生物学活性的毒素A C端结构域重组蛋白。免疫产蛋鸡后获得了效价1∶50 000的抗艰难梭菌毒素A的卵黄抗体。结论获得了具有生物学活性的艰难梭菌毒素A C端结构域重组蛋白,为建立艰难梭菌基因工程疫苗打下了基础,并制备了针对艰难梭菌毒素蛋白A的卵黄抗体,可用于艰难梭菌相关性腹泻的诊断和治疗。 Objective To express the C-terminal domains of toxin A for the development of egg yolk immunoglobulin against Clostridium difficile-associated diarrhea.Methods The DNA sequence of C-terminal domain of toxin A(TcdA-C) was optimized and synthesized.The gene was cloned into pET32b(+) vector before the recombinant vectors were transformed to E.coli BL21(DE3) competent cells.Fusion protein was purified by high affinity Ni+resin.After thrombin digestion,TcdA-C without tag was recovered from flow through of another round of high affinity Ni+resin purification.Biological activities of TcdA-C were assayed.High potency specific IgY antibodies against TcdA-C were prepared from immunization of egg laying hens,then the IgY antibodies were purified.Results Soluble recombinant TcdA-C protein was expressed in E.coli at a high level,and with good biological activity.The titer of prepared TcdA-C specific IgY antibodies was 1∶ 50 000.Purified IgY had neutralization activity in rabbit intestinal loop test.Conclusion Recombinant TcdA-C protein with native biological activities is successfully expressed and purified,which helps develop recombinant vaccines of C.difficile.IgY antibodies against the TcdA-C protein can be used for diagnosis and treatment of C.difficile-associated diarrhea.
出处 《军事医学》 CAS CSCD 北大核心 2013年第9期676-680,共5页 Military Medical Sciences
关键词 艰难梭菌毒素A 重组蛋白 卵黄抗体(IgY) Clostridium difficile toxin A recombinant protein egg yolk immunoglobulin(IgY)
  • 相关文献

参考文献10

  • 1Bosse D, Lemire C, Ruel J, et al. Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium diffi- cile infection[ J]. Infection,2012, 32(12) : 1110 - 1118.
  • 2Lowy I, Molrine DC, Lear BA, et al. Treatment with monoclonal antibodies against Clostddittm diffwile toxins[ J]. N Engl J Med, 2010, 362(3): 197-205.
  • 3Babcock GJ, Broering TJ, Hernandez HJ, et al. Human mono- clonal antibodies directed against toxins A and B prevent Clostrid- ium difficile-induced mortality in hamsters [ J ]. Infect Immun, 2006,74( 11 ) :6339 -6347.
  • 4Roberts A, McGlashan J, Al-Abdulla I, et al. Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection[ J. Infect Immun ,2012, 80 ( 2 ) : 875 - 882.
  • 5Li X, Liu H, Xu Y, et al. Chicken egg yolk antibody (IgY) controls Solobacterium moorei under in vitro and in vivo conditions [J]. Appl Biochem Biotechnol, 2011, 168(6) : 1448 - 1458.
  • 6Ko KY, Ahn DU. Preparation of immunoglobulin Y from egg yolk using ammonium sulfate precipitation and ion exchange chroma- tography[J]. Poult Sci, 2007, 86(2) : 400 -407.
  • 7Xu FX, Xu YP, Jin LJ, et al. Effectiveness of egg yolk immuno- globulin (IgY) against periodontal disease-causing Fusobacterium nucleatum[ J]. Appl Microbiol, 2010, 113 (4) : 983 - 991.
  • 8Parma YR, Chacana PA, Lucchesi PM, et al. Detection of Shiga toxin-producing Escherichia coli by sandwich enzyme-linked im- munosorbent assay using chicken egg yolk IgY antibodies [ J]. Front Cell Infect Microbial, 2009, 10(2) :84.
  • 9Spillner E, Braren I, Greunke K, et al. Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy [ J ]. Biologicals, 2007, 40 (5) : 313 - 322.
  • 10Xu Y, Li X, Jin L, et al. Application of chicken egg yolk immu- noglobulins in the control of terrestrial and aquatic animal disea- ses : a review[ J]. Biotechnol Adv, 2010, 29 (6) :860 - 868.

同被引文献54

  • 1Fa-Ming Zhang,Hong-Gang Wang,Min Wang,Bo-Ta Cui,Zhi-Ning Fan,Guo-Zhong Ji.Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease[J].World Journal of Gastroenterology,2013,19(41):7213-7216. 被引量:83
  • 2Li XY, Liu H, Xu YP, et al. Chicken Egg Yolk Antibody (IgY) controls solobacterium moore under in vitro and in vivo condi- tions[J]. Appl Bio-chem Biorechnol, 2012, 168: 1448-1458. DOI: 10. 1007/s12010-012-9869-3.
  • 3Tan SH, Moharnedali A, Kaput A, et al. A novel, cost-effective and effieierxt chicken egg IgY purification procedure[J]. J Immu- nological Methods, 2012, 380: 73-76. DOI: 10. 1016/j. jim. 2012.03. 003.
  • 4Marcet I, Laca A, Paredes B, et al. IgY isolation from a watery by-product obtained from an egg yolk fractionation processEJ]. Food Bioproducts proc, 2011, 89: 87-91. DOI: 10. 1016/i. fhp. 2010.04. 006.
  • 5Dias da Silva W, Tambourgi DV. IgY.. A promising antibody for use in mraunodiagnostic and in immunotherapy[J]. Vet Immunol Immunopathol, 2010, 135: 173-180. DOI: 10. 1016/j. vetimm. 2009.12. 011.
  • 6Pauly D, Chacana PA, Calzado EG, et al. IgY technology: ex- traction of chicken antibodies from egg yolk by polyethylene gly- col (PEG) precipitation[J]. J Vis Exp, 2011, 10: 1-5. DOI: 10. 3791/3084.
  • 7Schade R, Calzado EG, Sarmiento R, et al. Chicken egg yolk antibodies (IgY-technology) : a review of progress in production and use in research and human and veterinary medicine[J]. A1- tern Lab Anim, 2005, 33(2): 129-154.
  • 8Xu YP, Li XY, Jin LJ, et al. Application of chicken egg yolk immunoglobulins in the control of terrestrial and aquatic animal diseases: A review[J]. Biotechnol Adv, 2011, 29; 860-868. DOI: 10. 1016/i. biotechadv. 2011.07. 003.
  • 9Schreiner B, Birgit C, Gobel VTW. A striking example of con- vergent evolution observed for the ggFcR: IgY interaction closely resembling that of mammalian FeR: IgG[J]. Developmental Comparat Immunol, 2012, 36:566 571. DOI: 10. 1016/j. dci. 2011. 09. 013.
  • 10Liou JF, Chang CW, Tailiu JJ, et al. Passive protection effect of chicken egg yolk immunoglobulins on enterovirus 71 infected mice[J]. Vaccine, 2010, 28: 8189-8196. DOI: 10.1016/j. vac cine. 2010.09. 089.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部